AxonPrime Infrastructure Acquisition (APMI) 10-Q 21 Nov 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 18, 2022
Entity Listings [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Document Transition Report	false
Entity File Number	001-40740
Entity Registrant Name	AXONPRIME INFRASTRUCTURE ACQUISITION CORP
Entity Central Index Key	0001857662
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	86-3116385
Entity Address, Address Line One	126 E. 56th St., 30th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	479-2000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Units [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A common stock and one-third of one warrant
Trading Symbol	APMIU
Security Exchange Name	NASDAQ
Class A Common Stock [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	APMI
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		15,000,000
Warrants [Member]
Entity Listings [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
Trading Symbol	APMIW
Security Exchange Name	NASDAQ
Class B Common Stock [Member]
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		3,750,000

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash	$ 35,275	$ 449,254
Prepaid insurance	434,969	565,548
Total current assets	470,244	1,014,802
Investment held in Trust Account	150,909,712	150,000,566
Long-term prepaid insurance	0	329,901
Total Assets	151,379,956	151,345,269
Current Liabilities
Accounts payable	713,257	447,434
Accrued expenses	445,434	501,138
Franchise tax payable	301,374	151,374
Income tax payable	159,421	0
Due to related party	53,861	0
Total current liabilities	1,673,347	1,099,946
Deferred underwriting fee payable	5,250,000	5,250,000
Warrant liabilities	833,333	6,200,000
Total liabilities	7,756,680	12,549,946
Commitments and Contingencies
Class A common stock subject to possible redemption, $0.0001 par value; 15,000,000 shares subject to possible redemption at $10.02 per share at September 30, 2022 and December 31, 2021, respectively	150,348,917	150,000,000
Stockholders' Deficit
Preferred Stock - $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding at September 30, 2022 and December 31, 2021	0	0
Additional paid-in capital	0	0
Accumulated deficit	(6,726,016)	(11,205,052)
Total stockholders' deficit	(6,725,641)	(11,204,677)
Total Liabilities, Class A Common Stock subject to Possible Redemption and Stockholders' Deficit	151,379,956	151,345,269
Class A Common Stock [Member]
Stockholders' Deficit
Common shares - $0.0001 par value	0	0
Class B Common Stock [Member]
Stockholders' Deficit
Common shares - $0.0001 par value	$ 375	$ 375

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Stockholders' Deficit
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A Common Stock [Member]
LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDER'S DEFICIT
Common stock, subject to possible redemption, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, redemption (in shares)	15,000,000	15,000,000
Common stock, redemption price per share (in dollars per share)	$ 10.02	$ 10
Stockholders' Deficit
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	0	0
Common stock, shares outstanding (in shares)	0	0
Class B Common Stock [Member]
Stockholders' Deficit
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	3,750,000	3,750,000
Common stock, shares outstanding (in shares)	3,750,000	3,750,000

UNAUDITED CONDENSED STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022
Loss from Operations [Abstract]
Formation costs and other operating expenses	$ 217,855	$ 67,092	$ 69,022	$ 1,138,439
Franchise tax expense	50,000	0	0	150,000
Loss from operations	(267,855)	(67,092)	(69,022)	(1,288,439)
Other income (expense):
Income earned on marketable securities held in Trust Account	682,181	0	0	909,146
Warrant offering expense	0	(289,574)	(289,574)	0
Offering costs related to transferring founder shares to anchor investors	0	(141,870)	(141,870)	0
Change in fair value of warrant liabilities	1,083,334	(783,333)	(783,333)	5,366,667
Net income (loss) before provision for income taxes	1,497,660	(1,281,869)	(1,283,799)	4,987,374
Provision for income taxes	159,421	0	0	159,421
Net income (loss)	$ 1,338,239	$ (1,281,869)	$ (1,283,799)	$ 4,827,953
Class A Common Stock [Member]
Other income (expense):
Weighted average common stock outstanding, basic (in shares)	15,000,000	7,252,747	3,708,791	15,000,000
Weighted average common stock outstanding, diluted (in shares)	15,000,000	7,252,747	3,708,791	15,000,000
Basic net income (loss) per share (in dollars per share)	$ 0.07	$ (0.12)	$ (0.17)	$ 0.26
Diluted net income (loss) per share (in dollars per share)	$ 0.07	$ (0.12)	$ (0.17)	$ 0.26
Class B Common Stock [Member]
Other income (expense):
Weighted average common stock outstanding, basic (in shares)	3,750,000	3,750,000	3,750,000	3,750,000
Weighted average common stock outstanding, diluted (in shares)	3,750,000	3,750,000	3,750,000	3,750,000
Basic net income (loss) per share (in dollars per share)	$ 0.07	$ (0.12)	$ (0.17)	$ 0.26
Diluted net income (loss) per share (in dollars per share)	$ 0.07	$ (0.12)	$ (0.17)	$ 0.26

UNAUDITED CONDENSED STATEMENT_2

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Common Stock [Member] Class B Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Mar. 31, 2021	$ 0	$ 0	$ 0	$ 0
Beginning balance (in shares) at Mar. 31, 2021	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B common stock to Sponsor	$ 431	24,569	0	25,000
Issuance of Class B common stock to Sponsor (in shares)	4,312,500
Net income (loss)	$ 0	0	(1,930)	(1,930)
Ending balance at Jun. 30, 2021	$ 431	24,569	(1,930)	23,070
Ending balance (in shares) at Jun. 30, 2021	4,312,500
Beginning balance at Mar. 31, 2021	$ 0	0	0	0
Beginning balance (in shares) at Mar. 31, 2021	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				(1,283,799)
Ending balance at Sep. 30, 2021	$ 375	0	(13,014,688)	(13,014,313)
Ending balance (in shares) at Sep. 30, 2021	3,750,000
Beginning balance at Jun. 30, 2021	$ 431	24,569	(1,930)	23,070
Beginning balance (in shares) at Jun. 30, 2021	4,312,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Excess of cash received over fair value of private placement warrants		1,266,667		1,266,667
Forfeiture of Class B common stock	$ (56)	56
Forfeiture of Class B common stock (in shares)	(562,500)
Accretion for Class A common stock to redemption amounts		(1,291,292)	(11,730,889)	(13,022,181)
Net income (loss)			(1,281,869)	(1,281,869)
Ending balance at Sep. 30, 2021	$ 375	0	(13,014,688)	(13,014,313)
Ending balance (in shares) at Sep. 30, 2021	3,750,000
Beginning balance at Dec. 31, 2021	$ 375	0	(11,205,052)	(11,204,677)
Beginning balance (in shares) at Dec. 31, 2021	3,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 0	0	1,936,589	1,936,589
Ending balance at Mar. 31, 2022	$ 375	0	(9,268,463)	(9,268,088)
Ending balance (in shares) at Mar. 31, 2022	3,750,000
Beginning balance at Dec. 31, 2021	$ 375	0	(11,205,052)	(11,204,677)
Beginning balance (in shares) at Dec. 31, 2021	3,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				4,827,953
Ending balance at Sep. 30, 2022	$ 375	0	(6,726,016)	(6,725,641)
Ending balance (in shares) at Sep. 30, 2022	3,750,000
Beginning balance at Mar. 31, 2022	$ 375	0	(9,268,463)	(9,268,088)
Beginning balance (in shares) at Mar. 31, 2022	3,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 0	0	1,553,125	1,553,125
Ending balance at Jun. 30, 2022	$ 375	0	(7,715,338)	(7,714,963)
Ending balance (in shares) at Jun. 30, 2022	3,750,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A common stock to redemption amounts	$ 0	0	(348,917)	(348,917)
Net income (loss)	0	0	1,338,239	1,338,239
Ending balance at Sep. 30, 2022	$ 375	$ 0	$ (6,726,016)	$ (6,725,641)
Ending balance (in shares) at Sep. 30, 2022	3,750,000

UNAUDITED CONDENSED STATEMENT_3

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended				6 Months Ended	9 Months Ended
	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
Cash flow from operating activities:
Net income (loss)	$ 1,338,239	$ 1,936,589	$ (1,281,869)	$ (1,930)	$ (1,283,799)	$ 4,827,953
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on marketable securities held in trust account	(682,181)		0		0	(909,146)
Change in fair value of warrant liabilities					783,333	(5,366,667)
Offering expenses - warrants and anchor investors					431,444	0
Changes in operating assets and liabilities:
Prepaid insurance					(1,083,964)	460,480
Accounts payable					0	265,823
Accrued expenses					329,655	(55,704)
Franchise tax payable					0	150,000
Income tax payable					0	159,421
Due to related party					0	53,861
Net Cash used in Operating Activities					(823,331)	(413,979)
Cash flow from investing activities:
Investment held in Trust Account					(150,000,000)	0
Net Cash used in Investing Activities					(150,000,000)	0
Cash flow from financing activities:
Proceeds received from initial public offering					150,000,000	0
Proceeds from Promissory note payable					121,138	0
Repayments of Promissory note payable					(121,138)	0
Proceeds from private warrants					5,000,000	0
Payment of offering costs					(3,428,625)	0
Net Cash used in Financing Activities					151,571,375	0
Net change in cash					748,044	(413,979)
Cash at the beginning of the period		$ 449,254		$ 0	0	449,254	$ 0
Cash at the end of the period	$ 35,275		$ 748,044		748,044	35,275	$ 449,254
Non-cash investing and financing activities:
Offering costs included in accrued offering costs					25,000	0
Deferred underwriting commissions					5,250,000	0
Offering costs paid by Sponsor in exchange for issuance of Class B common stock					25,000	0
Offering costs included in Due to Sponsor					$ 52,250	$ 0

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	9 Months Ended
	Sep. 30, 2022
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS [Abstract]
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AxonPrime Infrastructure Acquisition Corporation (the “Company”) is a blank check company incorporated in the state of Delaware on April 1, 2021. The Company was formed for the purpose of effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of September 30, 2022, the Company had not yet commenced any operations. All activity for the period April 1, 2021 (inception) through September 30, 2022 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) which is described below, and, since the closing of the Initial Public Offering, the Company’s search for Business Combination candidates. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company’s sponsor is AxonPrime Infrastructure Sponsor LLC (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective by the Securities and Exchange Commission (the “SEC”) on August 12, 2021. On August 17, 2021, the Company consummated its Initial Public Offering of 15,000,000 units (the “Units” and, with respect to the Class A common stock included in the Units, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $150,000,000 (see Note 3). As part of the Initial Public Offering, certain institutional anchor investors (the “Institutional Anchor Investors”) not then affiliated with the Company, the Sponsor, or the Company’s officers, directors, or any member of the Company’s management purchased an aggregate of 12,790,000 Units. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $127,900,000 which is included in the gross proceeds of $150,000,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 3,333,333 warrants (the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement (“Private Placement”) to the Sponsor, generating gross proceeds of $5,000,000 (see Note 4). Substantially concurrently with the closing of the Private Placement, the Sponsor sold an aggregate of 66,666 Private Placement Warrants to the Institutional Anchor Investors for $100,000. During the closing of the IPO, the Institutional Anchor Investors also purchased 650,000 shares of Class B common Stock (“Founder Shares”) from the Sponsor at the original purchase price of $0.003 per share (see Note 5). The Founder Shares will automatically convert into shares of Class A common stock at the time of the Company’s Business Combination on a one-for-one basis, subject to adjustment as provided in the Company’s final prospectus, dated August 12, 2021, as filed with the SEC on August 16, 2021 (“Final Prospectus”). The Company incurred offering costs in the Public Offering totaling $8,703,625, consisting of $3,000,000 of underwriting fees, $5,250,000 of deferred underwriting fees and $453,625 of other offering costs. Following the closing of the Initial Public Offering on August 17, 2021, an amount of $150,000,000 from the net proceeds of the sale of the Units in the Initial Public Offering and additional proceeds from the sale of the Private Placement Warrants were placed in a trust account (the “Trust Account”) located in the United States and are invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (as defined above) (less any deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the signing a definitive agreement to enter a Business Combination. The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company will provide its holders of the outstanding Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination pursuant to the proxy solicitation rules of the SEC or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company will be required to seek shareholder approval of a Business Combination at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and a majority of the outstanding shares voted are voted in favor of the Business Combination. If the Company conducts redemptions of the Public Shares in connection with a Business Combination pursuant to the proxy solicitation rules in conjunction with a shareholder meeting instead of pursuant to the tender offer rules, the Company’s second amended and restated certificate of incorporation (the “Certificate of Incorporation”) provides that a public stockholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent. The public stockholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. These shares of Class A common stock are recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” If the Company is unable to conduct redemptions pursuant to the proxy solicitation rules as described above, the Company will, pursuant to its Certificate of Incorporation, offer such redemption pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. The Company’s Sponsor, officers, directors, and advisors have agreed (a) to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment to the Company’s Certificate of Incorporation with respect to the Company’s pre-Business Combination activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) into cash from the Trust Account in connection with a shareholder vote to approve a Business Combination (or to sell any shares in a tender offer in connection with a Business Combination if the Company is unable to conduct redemptions pursuant to the proxy solicitation rules) or a vote to amend the provisions of the Certificate of Incorporation relating to shareholders’ rights of pre-Business Combination activity and (d) that the Founder Shares shall not participate in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the Sponsor and the Company’s officers, directors and advisors will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering if the Company fails to complete its Business Combination. The Institutional Anchor Investors have agreed to (a) vote any Founder Shares held by them in favor of the Company’s initial Business Combination, (b) subject any Founder Shares and Private Placement Warrants, if applicable, held by them to substantially the same transfer restrictions as the Founder Shares and Private Placement Warrants, respectively, held by the Sponsor and the officers and directors described above and (c) waive any right, title, interest or claim of any kind in or to any monies held in the trust account (including applicable redemption rights or rights to liquidating distributions), or any other asset of the Company as a result of any liquidation of the Company, with respect to any Founder Shares held by them. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or August 17, 2023 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than 10 business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations under Delaware law to provide for claims of creditors and the requirements of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the price per Unit of $10.00. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the day of liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations, and believes that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure its shareholders that the Sponsor would be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Going Concern As of September 30, 2022, the Company had $35,275 in its operating bank account and had a working capital deficit of $1,203,103. To date, the Company’s liquidity needs have been satisfied through a payment of $25,000 from the Sponsor to cover certain expenses on behalf of the Company in exchange for the issuance of the Founder Shares (as defined in Note 5), a loan of approximately $121,000 pursuant to the Note issued to the Sponsor (see Note 5), and the net proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note on September 8, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s officers, directors and Initial Shareholders may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). As of September 30, 2022, there were no Working Capital Loans outstanding. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) - “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until August to consummate the initial Business Combination. It is uncertain that the Company will be able to consummate the initial Business Combination by this time. If a business combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the mandatory liquidation, should a business combination not occur, and potential subsequent dissolution, raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after August The Company intends to complete the initial Business Combination before the mandatory liquidation date. However, there can be no assurance that the Company will be able to consummate any business combination by August

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K filed with SEC on March 31, 2022. The interim results for the three and nine months ended September 30, 2022, are not necessarily indicative of the results to be expected for the year ending December 31, 2022. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company, which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. This may make comparison of the Company’s unaudited condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and judgements are used in, among other things, estimating fair value of warrant liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2022 and December 31, 2021, respectively. Investments Held in Trust Account The Company’s portfolio of investments held in trust consists solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company’s effective tax rate was 0.76% and 3.20% for the three and nine months ended September 30, 2022, respectively, 0.00% for the three months ended September 30, 2021, and 0.00% for the period from April 1, 2021 (inception) through September 30, 2021. The Company’s effective income tax rate for the three and nine months ended September 30, 2022 differed from the statutory rate of 21% primarily due to the change in the valuation allowance for deferred tax assets related primarily to the capitalization of start-up costs. The Company has identified the United States as its only “major” tax jurisdiction. The Company is incorporated in the state of Delaware and is required to pay franchise taxes to the State of Delaware on an annual basis. Net Income (Loss) per Share of Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding for the period. This presentation assumes a business combination as the most likely outcome. The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted net income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 8,333,333 shares of Class A common stock in the aggregate. At September 30, 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common stock is the same as basic net income (loss) per common stock for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per share (in dollars, except per share amounts): For the Three Months Ended September 30, 2022 For the Three Month Ended September 30, 2021 For the Nine Months ended September 30, 2022 For the Period from April 1, 2021 (inception) through September 30, 2021 Class A Class B Class A Class B Class A Class B Class A Class B EPS Numerator: Net income (loss) Allocation of net income (loss) $ 1,070,591 $ 267,648 $ (844,977 ) $ (436,892 ) $ 3,862,362 $ 965,591 $ (638,353 ) $ (645,446 ) Denominator: Basic and diluted weighted average shares outstanding 15,000,000 3,750,000 7,252,747 3,750,000 15,000,000 3,750,000 3,708,791 3,750,000 Basic and diluted net income (loss) per common stock $ 0.07 $ 0.07 $ (0.12 ) $ (0.12 ) $ 0.26 $ 0.26 $ (0.17 ) $ (0.17 ) Offering Costs Associated with the Initial Public Offering Offering costs of legal, accounting, underwriting fees and other costs incurred that are directly related to the Initial Public Offering were charged to temporary equity at the completion of the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as non-operating expenses in the condensed statements of operations. Offering costs associated with the Public Shares were charged to the carrying value of the shares of Class A common stock subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Warrant Liabilities The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, “Distinguishing Liabilities” from Equity (“ASC 480”), and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the private warrants were estimated using a Monte Carlo simulation model-based approach (see Note 10). The measurements of fair market value of the Public Warrants were initially estimated using a Monte Carlo simulation model-based approach. As of September 30, 2022 and December 31, 2021, the Public Warrants are calculated based on the market price of the Public Warrants, which trade under the ticker symbol APMIW. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution, which at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account, and management believes the Company is not exposed to significant risks on such account. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480, “Distinguishing Liabilities from Equity.” The shares of Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable shares of Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2022, and December 31, 2021, 15,000,000 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit. At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets is reconciled in the following table: Gross Proceeds $ 150,000,000 Less: Proceeds allocated to Public Warrants (4,750,000 ) Class A common stock issuance costs (8,272,181 ) Add: Accretion of carrying value to redemption value 13,022,181 Class A common stock subject to possible redemption at December 31, 2021 150,000,000 Accretion of carrying value to redemption value 348,917 Class A common stock subject to possible redemption at September 30, 2022 $ 150,348,917 Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying condensed balance sheets, due to their short-term nature except for warrant liabilities (see Note 10). The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities. Recently Issued Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, “Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40)” (“ASU 2020-06”), to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. As a smaller reporting company, ASU 2020-06 is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. The Company’s

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	9 Months Ended
	Sep. 30, 2022
INITIAL PUBLIC OFFERING [Abstract]
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING On August 17, 2021, the Company sold 15,000,000 Units at $10.00 per Unit, generating gross proceeds of $150,000,000, and incurring offering costs totaling $8,703,625, consisting of $3,000,000 of underwriting fees, $5,250,000 of deferred underwriting fees and $453,625 of other offering costs. Each Unit consists of one of the Company’s Class A common stock, par value $0.0001 per share, and one-third As part of the Initial Public Offering, certain Institutional Anchor Investors not then affiliated with the Company, the Sponsor, or the Company’s officers, directors, or any member of the Company’s management purchased an aggregate of 12,790,000 Units at the offering price of $10.00 per Unit.

PRIVATE PLACEMENT

PRIVATE PLACEMENT	9 Months Ended
	Sep. 30, 2022
PRIVATE PLACEMENT [Abstract]
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased 3,333,333 Private Placement Warrants at a price of $1.50 per warrant, generating total proceeds of $5,000,000 to the Company. Substantially concurrently with the closing of the Private Placement, the Sponsor sold an aggregate of 66,666 Private Placement Warrants to the Institutional Anchor Investors for $100,000. Each Private Placement Warrant is identical to the warrants offered in the Initial Public Offering, except there will be no redemption rights or liquidating distributions from the trust account with respect to Private Placement Warrants, which will expire worthless if the Company does not consummate a Business Combination within the Combination Period.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2022
RELATED PARTY TRANSACTIONS [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares and Initial Public Offering On April 9, 2021, one of the Company’s founders paid $25,000, or approximately $0.003 per share, to cover certain offering costs in consideration for 8,625,000 Class B common stock, par value $0.0001 (the “Founder Shares”). Subsequently, on April 19, 2021, all Founder Shares were assigned to the Sponsor. On July 6, 2021, the Sponsor surrendered an aggregate of 4,312,500 shares of Class B common stock for no consideration, which were cancelled resulting in an aggregate of 4,312,500 shares of Class B common stock outstanding as of such date The Company granted the underwriter a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 2,250,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less underwriting discounts and commissions. Following the expiration of the underwriter’s over-allotment option on September 26, 2021, 562,500 Founder Shares were forfeited by the Sponsor resulting in an aggregate amount outstanding of 3,750,000 Founder Shares as of September 30, 2022 and December 31, 2021. The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares until the earlier to occur of (A) one year after the completion of a Business Combination or (B) following the completion of an initial Business Combination, the date on which the Company completes a liquidation, merger, capital stock exchange or similar transaction that results in the Company’s shareholders having the right to exchange their common stock for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-day trading period commencing at least 150 days after the Business Combination, the Founder Shares will be released from the lock-up. In connection with the closing of the Initial Public Offering, the Sponsor sold 650,000 shares of Class B common stock (“Founder Shares”) to the Institutional Anchor Investors at the original purchase price of $0.003 per share. In addition, certain investment funds managed by an affiliate of the Sponsor purchased an aggregate of 15,000,000 Units as part of the Initial Public Offering. These Units were sold at the public offering price of $10.00 per Unit, generating gross proceeds to the Company of $150,000,000. Promissory Note — Related Party On April 9, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note is non-interest bearing and is payable on the earlier of (i) December 31, 2021 or (ii) the consummation of the Initial Public Offering. The Company borrowed approximately $121,000 under the Note. The Company fully repaid this balance on September 8, 2021. As of September Due to Related Party As of September Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.50 per warrant. The warrants will be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of September 30, 2022 and December Administrative Services Agreement Commencing on the date the Company’s securities were first listed, the Company agreed to pay the Sponsor a total of $10,000 per month for office space, secretarial and administrative services provided to the members of the Company’s management team. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees . The Company incurred approximately $30,000 and $90,000 in connection with such services for the three and nine months ended September , 2022, which are included in other operating expenses in the accompanying unaudited condensed statements of operations. As of September

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2022
COMMITMENTS AND CONTINGENCIES [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6. COMMITMENTS AND CONTINGENCIES Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and in each case holders of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement signed on the closing date of the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A common stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. U nderwriting The Company granted the underwriter a 45-day option to purchase up to 2,250,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. The underwriter’s over-allotment option was not exercised and expired on September 26, 2021. The underwriter was paid a cash underwriting discount of 2.00% of the gross proceeds of the Initial Public Offering, or $3,000,000, in connection with the Initial Public Offering. In addition, the underwriter is entitled to a deferred fee of three and half percent Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy is not determinable as of the date of these condensed financial statements, and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these unaudited condensed financial statements. Inflation Reduction Act of 2022 On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination

WARRANT LIABILITIES

WARRANT LIABILITIES	9 Months Ended
	Sep. 30, 2022
WARRANT LIABILITIES [Abstract]
WARRANT LIABILITIES	NOTE 7. WARRANT LIABILITIES The Company accounts for the 8,333,333 warrants issued in connection with the Initial Public Offering (5,000,000 Public Warrants and 3,333,333 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company has classified each warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s unaudited condensed statements of operations. Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the consummation of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years from the consummation of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A common stock pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their Public Warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement registering the issuance, under the Securities Act, of the Class A common stock issuable upon exercise of the Public Warrants. The Company will use its best efforts to file with the SEC a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Redemption of public warrants when the price per Class A common stock equals or exceeds $18.00 . Once the public warrants become exercisable, the Company may redeem the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per Public Warrant; ● upon a minimum of 30 days’ prior written notice of redemption, which the Company refers to as the 30-day redemption period; and ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of Class A common stock and equity-linked securities as described below) for any 20 trading days within a 30-day trading period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available throughout the 30-day redemption period. If and when the warrants become redeemable, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants when the price per Class A common stock equals or exceeds $10.00 Once the Warrants become exercisable, the Company may redeem the Warrants for redemption: ● in whole and not in part; ● at a price of $0.10 per warrant provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares of Class A common stock determined by reference to the table set forth under “Description of Securities — Warrants — Public Stockholders’ Warrants” in the Final Prospectus based on the redemption date and the “fair market value” of the Class A common stock (as defined below) except as otherwise described in “Description of Securities — Warrants — Public Stockholders’ Warrants”; ● upon a minimum of 30 days’ prior written notice of redemption; ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company will send the notice of redemption to the warrant holders; ● if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given; and ● if, and only if, the last reported sale price of the Company’s Class A common stock is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and the like), the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. If and when the Public Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of common stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the consummation of such initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the greater of the Market Value and the Newly Issued Price. The Private Placement Warrants will be identical to the Public Warrants included in the Units being sold in the Initial Public Offering, except that the Private Placement Warrants and the shares of common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and will be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	9 Months Ended
	Sep. 30, 2022
STOCKHOLDERS' DEFICIT [Abstract]
STOCKHOLDERS' DEFICIT	NOTE 8. STOCKHOLDERS’ DEFICIT Preferred stock — The Company is authorized to issue 1,000,000 shares of preferred stock of par value $0.0001 per share. At , there were no shares of preferred stock issued or outstanding. Class A common stock — The Company is authorized to issue up to 100,000,000 shares of Class A common stock, par value $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. At , there were no shares of Class A common stock issued or outstanding (excluding 15,000,000 shares subject to possible redemption) Class B common stock — The Company is authorized to issue up to 50,000,000 shares of Class B common stock, $0.0001 par value common stock. Holders of the Company’s Class B common stock are entitled to one vote for each share. At , there were 3,750,000 shares of Class B common stock issued or outstanding On April 9, 2021, one of the Company’s founders purchased an aggregate of 8,625,000 founder shares for an aggregate purchase price of $25,000, or approximately $0.003 per share. On April 19, 2021, the founder shares were assigned to the Company’s sponsor for the same purchase price that was initially paid by one of the Company’s founders. On July 6, 2021, the Sponsor surrendered an aggregate of 4,312,500 shares of Class B common stock for no consideration, which were cancelled resulting in an aggregate of 4,312,500 shares of Class B common stock outstanding as of such date. Of the 4,312,500 shares of Class B common stock, an aggregate of 562,500 shares were subject to forfeiture to the Company for no consideration to the extent that the underwriter’s over-allotment option is not exercised in full or in part, so that the initial stockholders collectively own 20% of the Company’s issued and outstanding common stock after the Initial Public Offering (excluding the Private Placement Shares and assuming the initial stockholders do not purchase any Class A common stock in the Initial Public Offering). Also on July 6, 2021, the Sponsor transferred an aggregate of 25,000 shares of Class B common stock to each of the Company’s independent director nominees (75,000 shares in total) at their original purchase price. On August 17, 2021, the Institutional Anchor Investors also purchased 650,000 shares of Class B common Stock from the Sponsor at the original purchase price of $0.003 per share. The Founder Shares will automatically convert into shares of Class A common stock at the time of the Company’s initial business combination on a one-for-one basis, subject to adjustment as provided in the Final Prospectus. Following the expiration of the underwriter’s over-allotment option, an aggregate of 3,750,000 founder shares were issued and outstanding as of (reflecting the forfeiture by the Sponsor of 562,500 founder shares). The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like. In the case that additional shares of Class A common stock, or equity linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time. The Company may issue additional common stock or preference shares to complete its Business Combination or under an employee incentive plan after completion of its Business Combination.

CLASS A ORDINARY SHARES SUBJECT

CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION	9 Months Ended
	Sep. 30, 2022
CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION [Abstract]
CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION	NOTE 9. CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. The Company is authorized to issue 100,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. Accordingly, as of September 30, 2022 and December 31, 2021, 15,000,000 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Sep. 30, 2022
FAIR VALUE MEASUREMENTS [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 10. FAIR VALUE MEASUREMENTS The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: As of September 30, As of December 31, Description Level 2022 2021 Assets: Investments held in Trust Account 1 $ 150,909,712 $ 150,000,566 Liabilities: Private Placement Warrants 3 $ 333,333 $ 2,500,000 Public Warrants 2 $ 500,000 $ — Public Warrants 1 $ — $ 3,700,000 Warrants The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the condensed balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the unaudited condensed statements of operations. Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period in which a change in valuation technique or methodology occurs. The Public warrants transferred from Level 1 to Level 2 during Q2 due to lack of trading volume and continues to be Level 2 due to the lack of trading volume. There were no other transfers to/from Levels 1, 2 or 3 during the nine months ended September 30, 2022. Initial Measurement The Company established the initial fair value for the Warrants on August 17, 2021, using a Monte Carlo simulation model for both the Public Warrants and the Private Placement Warrants. The Company allocated the proceeds received from (i) the Sale of Units (which is inclusive of one share of Class A common stock, and one-third The key inputs into the Monte Carlo simulation model for the Private Placement Warrants were as follows as of December 31, 2021: Input As of December 31, 2021 Risk-free interest rate 1.35 % Expected term (years) 5.00 Expected volatility 7.5 % Exercise price $ 11.50 Public stock price $ 9.82 Inherent in an options pricing model are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. • The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. • The expected life of the warrants is assumed to be equivalent to their remaining contractual term. • The Company estimates the volatility of its shares of common stock based on historical volatility that matches the expected remaining life of the warrants. • The dividend rate is based on the historical rate, which the Company anticipates to remain at zero. Subsequent Measurement The subsequent measurement of the Public Warrants as of September 30, 2022 is classified as Level 2 due to the lack of activity in the market under the ticker APMI. The Warrants are measured at fair value on a recurring basis. At the subsequent measurement date of September 30, 2022, the Private Placement Warrants were fair valued using the Monte Carlo Simulation Method. The fair value classification for the Private Placement Warrants remains unchanged as Level 3 from their initial valuation. The key inputs into the Monte Carlo simulation model for the Private Placement Warrants were as follows at subsequent measurement: Input As of September 30, 2022 Risk-free interest rate 4.25 % Expected term (years) 5.00 Expected volatility 2.90 % Exercise price $ 11.50 Public stock price $ 9.70 As of September 30, 2022, the aggregate values of the Private Placement Warrants and Public Warrants were $0.33 million and $0.5 million, respectively. The following table presents the changes in the fair value of the Level 3 private placement warrants liabilities: Private Placement Warrants Fair value as of December 31, 2021 $ 2,500,000 Change in valuation inputs or assumptions (1) (966,667 ) Fair value as of March 31, 2022 1,533,333 Change in valuation inputs or assumptions (1) (766,666 ) Fair value as of June 30, 2022 766,667 Change in valuation inputs or assumptions (1) (433,334 ) Fair value as of September 30, 2022 (2) $ 333,333 (1) Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the condensed statement of operations. (2) Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. There were no transfers in or out of Level 3 for the nine months ended September 30, 2022.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2022
SUBSEQUENT EVENTS [Abstract]
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS Management of the Company evaluated events that have occurred after the condensed balance sheets date through the date the unaudited condensed financial statements were issued. Based upon the review, management did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K filed with SEC on March 31, 2022. The interim results for the three and nine months ended September 30, 2022, are not necessarily indicative of the results to be expected for the year ending December 31, 2022.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and judgements are used in, among other things, estimating fair value of warrant liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of September 30, 2022 and December 31, 2021, respectively.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments held in trust consists solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof.
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The Company’s effective tax rate was 0.76% and 3.20% for the three and nine months ended September 30, 2022, respectively, 0.00% for the three months ended September 30, 2021, and 0.00% for the period from April 1, 2021 (inception) through September 30, 2021. The Company’s effective income tax rate for the three and nine months ended September 30, 2022 differed from the statutory rate of 21% primarily due to the change in the valuation allowance for deferred tax assets related primarily to the capitalization of start-up costs. The Company has identified the United States as its only “major” tax jurisdiction. The Company is incorporated in the state of Delaware and is required to pay franchise taxes to the State of Delaware on an annual basis.
Net Income (Loss) per Share of Common Stock	Net Income (Loss) per Share of Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding for the period. This presentation assumes a business combination as the most likely outcome. The Company has two classes of shares, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of shares. Accretion associated with the redeemable shares of Class A common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted net income (loss) per share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 8,333,333 shares of Class A common stock in the aggregate. At September 30, 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common stock is the same as basic net income (loss) per common stock for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per share (in dollars, except per share amounts): For the Three Months Ended September 30, 2022 For the Three Month Ended September 30, 2021 For the Nine Months ended September 30, 2022 For the Period from April 1, 2021 (inception) through September 30, 2021 Class A Class B Class A Class B Class A Class B Class A Class B EPS Numerator: Net income (loss) Allocation of net income (loss) $ 1,070,591 $ 267,648 $ (844,977 ) $ (436,892 ) $ 3,862,362 $ 965,591 $ (638,353 ) $ (645,446 ) Denominator: Basic and diluted weighted average shares outstanding 15,000,000 3,750,000 7,252,747 3,750,000 15,000,000 3,750,000 3,708,791 3,750,000 Basic and diluted net income (loss) per common stock $ 0.07 $ 0.07 $ (0.12 ) $ (0.12 ) $ 0.26 $ 0.26 $ (0.17 ) $ (0.17 )
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs of legal, accounting, underwriting fees and other costs incurred that are directly related to the Initial Public Offering were charged to temporary equity at the completion of the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as non-operating expenses in the condensed statements of operations. Offering costs associated with the Public Shares were charged to the carrying value of the shares of Class A common stock subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Warrant Liabilities	Warrant Liabilities The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, “Distinguishing Liabilities” from Equity (“ASC 480”), and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The fair value of the private warrants were estimated using a Monte Carlo simulation model-based approach (see Note 10). The measurements of fair market value of the Public Warrants were initially estimated using a Monte Carlo simulation model-based approach. As of September 30, 2022 and December 31, 2021, the Public Warrants are calculated based on the market price of the Public Warrants, which trade under the ticker symbol APMIW.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution, which at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account, and management believes the Company is not exposed to significant risks on such account.
Class A Common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in FASB ASC Topic 480, “Distinguishing Liabilities from Equity.” The shares of Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable shares of Class A common stock (including Class A common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of September 30, 2022, and December 31, 2021, 15,000,000 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in capital and accumulated deficit. At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets is reconciled in the following table: Gross Proceeds $ 150,000,000 Less: Proceeds allocated to Public Warrants (4,750,000 ) Class A common stock issuance costs (8,272,181 ) Add: Accretion of carrying value to redemption value 13,022,181 Class A common stock subject to possible redemption at December 31, 2021 150,000,000 Accretion of carrying value to redemption value 348,917 Class A common stock subject to possible redemption at September 30, 2022 $ 150,348,917
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying condensed balance sheets, due to their short-term nature except for warrant liabilities (see Note 10). The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances. The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities. Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals. Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, “Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40)” (“ASU 2020-06”), to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. As a smaller reporting company, ASU 2020-06 is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. The Company’s

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Calculation of Basic and Diluted Net Income Per Common Stock	The following table reflects the calculation of basic and diluted net income (loss) per share (in dollars, except per share amounts): For the Three Months Ended September 30, 2022 For the Three Month Ended September 30, 2021 For the Nine Months ended September 30, 2022 For the Period from April 1, 2021 (inception) through September 30, 2021 Class A Class B Class A Class B Class A Class B Class A Class B EPS Numerator: Net income (loss) Allocation of net income (loss) $ 1,070,591 $ 267,648 $ (844,977 ) $ (436,892 ) $ 3,862,362 $ 965,591 $ (638,353 ) $ (645,446 ) Denominator: Basic and diluted weighted average shares outstanding 15,000,000 3,750,000 7,252,747 3,750,000 15,000,000 3,750,000 3,708,791 3,750,000 Basic and diluted net income (loss) per common stock $ 0.07 $ 0.07 $ (0.12 ) $ (0.12 ) $ 0.26 $ 0.26 $ (0.17 ) $ (0.17 )
Class A Common Stock Subject to Possible Redemption	At September 30, 2022 and December 31, 2021, the Class A common stock reflected in the condensed balance sheets is reconciled in the following table: Gross Proceeds $ 150,000,000 Less: Proceeds allocated to Public Warrants (4,750,000 ) Class A common stock issuance costs (8,272,181 ) Add: Accretion of carrying value to redemption value 13,022,181 Class A common stock subject to possible redemption at December 31, 2021 150,000,000 Accretion of carrying value to redemption value 348,917 Class A common stock subject to possible redemption at September 30, 2022 $ 150,348,917

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 30, 2022
FAIR VALUE MEASUREMENTS [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2022 and December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: As of September 30, As of December 31, Description Level 2022 2021 Assets: Investments held in Trust Account 1 $ 150,909,712 $ 150,000,566 Liabilities: Private Placement Warrants 3 $ 333,333 $ 2,500,000 Public Warrants 2 $ 500,000 $ — Public Warrants 1 $ — $ 3,700,000
Key Inputs Into the Monte Carlo Simulation Model	The key inputs into the Monte Carlo simulation model for the Private Placement Warrants were as follows as of December 31, 2021: Input As of December 31, 2021 Risk-free interest rate 1.35 % Expected term (years) 5.00 Expected volatility 7.5 % Exercise price $ 11.50 Public stock price $ 9.82 The key inputs into the Monte Carlo simulation model for the Private Placement Warrants were as follows at subsequent measurement: Input As of September 30, 2022 Risk-free interest rate 4.25 % Expected term (years) 5.00 Expected volatility 2.90 % Exercise price $ 11.50 Public stock price $ 9.70
Changes in Fair Value of Level 3 Warrant Liabilities	The following table presents the changes in the fair value of the Level 3 private placement warrants liabilities: Private Placement Warrants Fair value as of December 31, 2021 $ 2,500,000 Change in valuation inputs or assumptions (1) (966,667 ) Fair value as of March 31, 2022 1,533,333 Change in valuation inputs or assumptions (1) (766,666 ) Fair value as of June 30, 2022 766,667 Change in valuation inputs or assumptions (1) (433,334 ) Fair value as of September 30, 2022 (2) $ 333,333 (1) Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the condensed statement of operations. (2) Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. There were no transfers in or out of Level 3 for the nine months ended September 30, 2022.

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS, Summary (Details)		6 Months Ended	9 Months Ended
	Aug. 17, 2021 USD ($) $ / shares shares	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) Business $ / shares	Dec. 31, 2021 USD ($)
Description of Organization and Business Operations [Abstract]
Gross proceeds from initial public offering		$ 150,000,000	$ 0
Gross proceeds from private placement		5,000,000	$ 0
Stock conversion basis of Class B to Class A ordinary shares at time of initial business combination			1
Offering costs	$ 8,703,625
Underwriting fees	3,000,000
Deferred underwriting fees	5,250,000
Other offering costs	$ 453,625
Net proceeds from Initial Public Offering and Private Placement		$ 150,000,000	$ 0
Cash deposited in Trust Account per Unit (in dollars per share) | $ / shares			$ 10
Minimum [Member]
Description of Organization and Business Operations [Abstract]
Number of operating businesses included in initial Business Combination | Business			1
Fair market value as percentage of net assets held in Trust Account included in initial Business Combination			80%
Post-transaction ownership percentage of the target business			50%
Net tangible asset threshold for redeeming Public Shares			$ 5,000,001
Percentage of Public Shares that can be redeemed without prior consent			15%
Maximum [Member]
Description of Organization and Business Operations [Abstract]
Net proceeds from Initial Public Offering and Private Placement (in dollars per share) | $ / shares			$ 10
Period to complete Business Combination from closing of Initial Public Offering			24 months
Period to redeem Public Shares if Business Combination is not completed within Initial Combination Period			10 days
Interest from Trust Account that can be held to pay dissolution expenses			$ 100,000
Institutional Anchor Investors [Member] | Founder Shares [Member]
Description of Organization and Business Operations [Abstract]
Share price (in dollars per share) | $ / shares	$ 0.003
Number of shares issued (in shares) | shares	650,000
Stock conversion basis of Class B to Class A ordinary shares at time of initial business combination	1
Initial Public Offering [Member]
Description of Organization and Business Operations [Abstract]
Gross proceeds from initial public offering				$ 150,000,000
Net proceeds from Initial Public Offering and Private Placement	$ 150,000,000
Net proceeds from Initial Public Offering and Private Placement (in dollars per share) | $ / shares	$ 10
Initial Public Offering [Member] | Public Shares [Member]
Description of Organization and Business Operations [Abstract]
Units issued (in shares) | shares	15,000,000
Share price (in dollars per share) | $ / shares	$ 10
Gross proceeds from initial public offering	$ 150,000,000
Initial Public Offering [Member] | Institutional Anchor Investors [Member]
Description of Organization and Business Operations [Abstract]
Units issued (in shares) | shares	12,790,000
Share price (in dollars per share) | $ / shares	$ 10
Gross proceeds from initial public offering	$ 127,900,000
Initial Public Offering [Member] | Institutional Anchor Investors [Member] | Founder Shares [Member]
Description of Organization and Business Operations [Abstract]
Share price (in dollars per share) | $ / shares			$ 0.003
Private Placement [Member] | Private Placement Warrants [Member]
Description of Organization and Business Operations [Abstract]
Share price (in dollars per share) | $ / shares	$ 1.5
Warrants issued (in shares) | shares	3,333,333
Gross proceeds from private placement	$ 5,000,000
Private Placement [Member] | Institutional Anchor Investors [Member] | Private Placement Warrants [Member]
Description of Organization and Business Operations [Abstract]
Warrants issued (in shares) | shares	66,666
Gross proceeds from private placement	$ 100,000

DESCRIPTION OF ORGANIZATION A_3

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS, Liquidity and Management's Plan (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Apr. 09, 2021
Liquidity and Management's Plan [Abstract]
Cash	$ 35,275	$ 449,254
Working capital deficit	(1,203,103)
Working Capital Loans [Member]
Liquidity and Management's Plan [Abstract]
Working capital loans outstanding	0
Sponsor [Member]
Liquidity and Management's Plan [Abstract]
Capital contribution	25,000
Sponsor [Member] | Promissory Note [Member]
Liquidity and Management's Plan [Abstract]
Working capital loans outstanding	$ 0	$ 0	$ 121,000

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Cash and Cash Equivalents (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Cash equivalents	$ 0	$ 0

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Investments Held in Trust Account (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Investments Held in Trust Account [Abstract]
Investment held in Trust Account	$ 150,909,712	$ 150,000,566

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Income Taxes (Details) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022
Income Taxes [Abstract]
Unrecognized tax benefits	$ 0			$ 0
Accrued interest and penalties	$ 0			$ 0
Effective tax rate	0.76%	0%	0%	3.20%
Statutory tax rate	21%			21%

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Net Income (Loss) Per Share of Common Stock (Details) - USD ($)	3 Months Ended		6 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022
Net Income (Loss) per Share of Common Stock [Abstract]
Dilutive securities (in shares)				0
Class A [Member]
Net Income (Loss) per Share of Common Stock [Abstract]
Warrants exercisable to purchase of aggregate class A common stock (in shares)	8,333,333			8,333,333
Numerator: [Abstract]
Allocation of net income (loss)	$ 1,070,591	$ (844,977)	$ (638,353)	$ 3,862,362
Denominator: [Abstract]
Basic weighted average shares outstanding (in shares)	15,000,000	7,252,747	3,708,791	15,000,000
Diluted weighted average shares outstanding (in shares)	15,000,000	7,252,747	3,708,791	15,000,000
Basic net income (loss) per common stock (in dollars per share)	$ 0.07	$ (0.12)	$ (0.17)	$ 0.26
Diluted net income (loss) per common stock (in dollars per share)	$ 0.07	$ (0.12)	$ (0.17)	$ 0.26
Class B [Member]
Numerator: [Abstract]
Allocation of net income (loss)	$ 267,648	$ (436,892)	$ (645,446)	$ 965,591
Denominator: [Abstract]
Basic weighted average shares outstanding (in shares)	3,750,000	3,750,000	3,750,000	3,750,000
Diluted weighted average shares outstanding (in shares)	3,750,000	3,750,000	3,750,000	3,750,000
Basic net income (loss) per common stock (in dollars per share)	$ 0.07	$ (0.12)	$ (0.17)	$ 0.26
Diluted net income (loss) per common stock (in dollars per share)	$ 0.07	$ (0.12)	$ (0.17)	$ 0.26

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Class A Common Stock Subject to Possible Redemption (Details) - USD ($)	6 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
Class A Common Stock Subject to Possible Redemption [Abstract]
Gross proceeds	$ 150,000,000	$ 0
Class A common stock issuance costs	$ (3,428,625)	0
Class A common stock subject to possible redemption		$ 150,348,917	$ 150,000,000
Class A Common Stock [Member]
Class A Common Stock Subject to Possible Redemption [Abstract]
Common stock, subject to possible redemption (in shares)		15,000,000	15,000,000
Initial Public Offering [Member]
Class A Common Stock Subject to Possible Redemption [Abstract]
Gross proceeds			$ 150,000,000
Accretion of carrying value to redemption value		$ 348,917	13,022,181
Initial Public Offering [Member] | Class A Common Stock [Member]
Class A Common Stock Subject to Possible Redemption [Abstract]
Class A common stock issuance costs			(8,272,181)
Class A common stock subject to possible redemption		$ 150,348,917	150,000,000
Initial Public Offering [Member] | Public Warrants [Member]
Class A Common Stock Subject to Possible Redemption [Abstract]
Proceeds allocated to public warrants			$ (4,750,000)

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - USD ($)		6 Months Ended	9 Months Ended
	Aug. 17, 2021	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
Initial Public Offering [Abstract]
Gross proceeds from initial public offering		$ 150,000,000	$ 0
Offering costs	$ 8,703,625
Underwriting fees	3,000,000
Deferred underwriting fees	5,250,000
Other offering costs	$ 453,625
Public Warrants [Member]
Initial Public Offering [Abstract]
Number of securities called by each unit (in shares)	0.33
Class A Common Stock [Member]
Initial Public Offering [Abstract]
Common stock, par value (in dollars per share)			$ 0.0001	$ 0.0001
Number of securities called by each unit (in shares)	1
Initial Public Offering [Member]
Initial Public Offering [Abstract]
Gross proceeds from initial public offering				$ 150,000,000
Initial Public Offering [Member] | Public Shares [Member]
Initial Public Offering [Abstract]
Units issued (in shares)	15,000,000
Share price (in dollars per share)	$ 10
Gross proceeds from initial public offering	$ 150,000,000
Initial Public Offering [Member] | Public Warrants [Member]
Initial Public Offering [Abstract]
Number of securities called by each unit (in shares)	0.33
Warrants exercise price (in dollars per share)	$ 11.5
Initial Public Offering [Member] | Class A Common Stock [Member]
Initial Public Offering [Abstract]
Number of securities called by each unit (in shares)	1
Number of securities called by each warrant (in shares)	1
Initial Public Offering [Member] | Institutional Anchor Investors [Member]
Initial Public Offering [Abstract]
Units issued (in shares)	12,790,000
Share price (in dollars per share)	$ 10
Gross proceeds from initial public offering	$ 127,900,000

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details) - USD ($)		6 Months Ended	9 Months Ended
	Aug. 17, 2021	Sep. 30, 2021	Sep. 30, 2022
Private Placement [Abstract]
Gross proceeds from issuance of warrants		$ 5,000,000	$ 0
Private Placement [Member] | Private Placement Warrants [Member]
Private Placement [Abstract]
Warrants issued (in shares)	3,333,333
Share price (in dollars per share)	$ 1.5
Gross proceeds from issuance of warrants	$ 5,000,000
Private Placement [Member] | Private Placement Warrants [Member] | Institutional Anchor Investors [Member]
Private Placement [Abstract]
Warrants issued (in shares)	66,666
Gross proceeds from issuance of warrants	$ 100,000

RELATED PARTY TRANSACTIONS, Fou

RELATED PARTY TRANSACTIONS, Founder Shares and Initial Public Offering (Details) - USD ($)				6 Months Ended	9 Months Ended
	Aug. 17, 2021	Jul. 06, 2021	Apr. 09, 2021	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
Founder Shares and Initial Public Offering [Abstract]
Gross proceeds from initial public offering				$ 150,000,000	$ 0
Class A Common Stock [Member]
Founder Shares and Initial Public Offering [Abstract]
Common stock, par value (in dollars per share)					$ 0.0001	$ 0.0001
Common stock, shares outstanding (in shares)					0	0
Class B Common Stock [Member]
Founder Shares and Initial Public Offering [Abstract]
Common stock, par value (in dollars per share)					$ 0.0001	$ 0.0001
Number of shares forfeited (in shares)		4,312,500
Common stock, shares outstanding (in shares)		4,312,500			3,750,000	3,750,000
Over-Allotment Option [Member]
Founder Shares and Initial Public Offering [Abstract]
Option for Underwriters to purchase additional Units, Term					45 days
Additional Units that can be purchased to cover over-allotments (in shares)	2,250,000
Over-Allotment Option [Member] | Maximum [Member]
Founder Shares and Initial Public Offering [Abstract]
Additional Units that can be purchased to cover over-allotments (in shares)					2,250,000
Initial Public Offering [Member]
Founder Shares and Initial Public Offering [Abstract]
Gross proceeds from initial public offering						$ 150,000,000
Institutional Anchor Investors [Member] | Class B Common Stock [Member]
Founder Shares and Initial Public Offering [Abstract]
Share price (in dollars per share)	$ 0.003
Number of shares issued (in shares)	650,000
Institutional Anchor Investors [Member] | Initial Public Offering [Member]
Founder Shares and Initial Public Offering [Abstract]
Share price (in dollars per share)	$ 10
Gross proceeds from initial public offering	$ 127,900,000
Institutional Anchor Investors [Member] | Initial Public Offering [Member] | Class B Common Stock [Member]
Founder Shares and Initial Public Offering [Abstract]
Share price (in dollars per share)					$ 0.003
Issuance of Class B ordinary shares to Sponsor (in shares)					650,000
Directors [Member] | Class B Common Stock [Member]
Founder Shares and Initial Public Offering [Abstract]
Issuance of Class B ordinary shares to Sponsor (in shares)		75,000
Director 1[Member] | Class B Common Stock [Member]
Founder Shares and Initial Public Offering [Abstract]
Issuance of Class B ordinary shares to Sponsor (in shares)		25,000
Director 2 [Member] | Class B Common Stock [Member]
Founder Shares and Initial Public Offering [Abstract]
Issuance of Class B ordinary shares to Sponsor (in shares)		25,000
Director 3 [Member] | Class B Common Stock [Member]
Founder Shares and Initial Public Offering [Abstract]
Issuance of Class B ordinary shares to Sponsor (in shares)		25,000
Sponsor [Member]
Founder Shares and Initial Public Offering [Abstract]
Proceeds from issuance of common stock					$ 25,000
Sponsor [Member] | Class A Common Stock [Member]
Founder Shares and Initial Public Offering [Abstract]
Share price (in dollars per share)					$ 12
Number of trading days					20 days
Trading day threshold period					30 days
Threshold period after initial Business Combination					150 days
Sponsor [Member] | Class B Common Stock [Member]
Founder Shares and Initial Public Offering [Abstract]
Proceeds from issuance of common stock			$ 25,000
Share price (in dollars per share)			$ 0.003
Issuance of Class B ordinary shares to Sponsor (in shares)			8,625,000
Common stock, par value (in dollars per share)			$ 0.0001
Number of shares forfeited (in shares)					562,500
Affiliate of Sponsor [Member] | Initial Public Offering [Member]
Founder Shares and Initial Public Offering [Abstract]
Share price (in dollars per share)					$ 10
Number of shares issued (in shares)					15,000,000
Gross proceeds from initial public offering					$ 150,000,000

RELATED PARTY TRANSACTIONS, Rel

RELATED PARTY TRANSACTIONS, Related Party (Details) - USD ($)		6 Months Ended	9 Months Ended
	Sep. 08, 2021	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021	Apr. 09, 2021
Promissory Note [Abstract]
Repayments of due amount		$ 121,138	$ 0
Due to related party			53,861	$ 0
Sponsor [Member] | Promissory Note [Member]
Promissory Note [Abstract]
Related party maximum borrowing amount					$ 300,000
Related party outstanding notes payable			0	$ 0	$ 121,000
Repayments of due amount	$ 121,000
Due to related party			$ 53,861

RELATED PARTY TRANSACTIONS, R_2

RELATED PARTY TRANSACTIONS, Related Party Loans (Details) - Working Capital Loans [Member] - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Related Party Loans [Abstract]
Related party outstanding notes payable	$ 0
Sponsor, Affiliate of Sponsor, or Certain Company Officers and Directors [Member]
Related Party Loans [Abstract]
Loans that can be converted into Warrants at lenders' discretion	$ 1,500,000
Conversion price (in dollars per share)	$ 1.5
Related party outstanding notes payable	$ 0	$ 0

RELATED PARTY TRANSACTIONS, Adm

RELATED PARTY TRANSACTIONS, Administrative Services Agreement (Details) - Sponsor [Member] - Administrative Support Agreement [Member] - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021
Administrative Support Agreement [Abstract]
Related party transaction amount		$ 10,000
Fees incurred	$ 30,000	90,000
Fees included in accrued expenses	$ 140,000	$ 140,000	$ 50,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details)		9 Months Ended
	Aug. 17, 2021 USD ($) shares	Sep. 30, 2022 Demand
Registration Rights [Abstract]
Number of demands entitled to holders | Demand		3
Underwriting Agreement [Abstract]
Underwriting fee discount percentage	2%
Underwriting discount	$ 3,000,000
Deferred underwriting fee percentage	3.50%
Deferred underwriting fees	$ 5,250,000
Over-Allotment Option [Member]
Underwriting Agreement [Abstract]
Term of option for underwriters to purchase additional units to cover over-allotments		45 days
Additional units that can be purchased to cover over-allotments (in shares) | shares	2,250,000

WARRANT LIABILITIES (Details)

WARRANT LIABILITIES (Details) - $ / shares		9 Months Ended
	Aug. 17, 2021	Sep. 30, 2022
Warrants [Abstract]
Period to exercise warrants after Business Combination		30 days
Period to exercise warrants after closing of Initial Public Offering		12 months
Expiration period of warrants		5 years
Period to file registration statement after initial Business Combination		15 days
Period for registration statement to become effective		60 days
Warrants [Member]
Warrants [Abstract]
Warrants issued (in shares)	8,333,333
Class A Common Stock [Member]
Warrants [Abstract]
Trading day period to calculate volume weighted average trading price		20 days
Redemption of Warrants When Price Equals or Exceeds $18.00 [Member]
Warrants [Abstract]
Warrant redemption price (in dollars per share)		$ 0.01
Notice period to redeem warrants		30 days
Threshold trading days		20 days
Threshold consecutive trading days		30 days
Redemption period		30 days
Percentage multiplier		180%
Redemption of Warrants When Price Equals or Exceeds $18.00 [Member] | Class A Common Stock [Member] | Minimum [Member]
Warrants [Abstract]
Share price (in dollars per share)		$ 18
Redemption of Warrants When Price Equals or Exceeds $10.00 [Member]
Warrants [Abstract]
Warrant redemption price (in dollars per share)		$ 0.1
Notice period to redeem warrants		30 days
Redemption of Warrants When Price Equals or Exceeds $10.00 [Member] | Class A Common Stock [Member] | Minimum [Member]
Warrants [Abstract]
Share price (in dollars per share)		$ 10
Additional Issue of Common Stock or Equity-Linked Securities [Member]
Warrants [Abstract]
Warrant redemption price (in dollars per share)		$ 18
Percentage multiplier		115%
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Minimum [Member]
Warrants [Abstract]
Aggregate gross proceeds from issuance as a percentage of total equity proceeds		60%
Additional Issue of Common Stock or Equity-Linked Securities [Member] | Class A Common Stock [Member] | Maximum [Member]
Warrants [Abstract]
Share price (in dollars per share)		$ 9.2
IPO [Member] | Warrants [Member]
Warrants [Abstract]
Warrants issued (in shares)	5,000,000
Private Placement Warrants [Member] | Warrants [Member]
Warrants [Abstract]
Warrants issued (in shares)	3,333,333

STOCKHOLDERS' DEFICIT (Details)

STOCKHOLDERS' DEFICIT (Details)				9 Months Ended
	Aug. 17, 2021 $ / shares shares	Jul. 06, 2021 shares	Apr. 09, 2021 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) Vote $ / shares shares	Dec. 31, 2021 $ / shares shares
Stockholders' Equity [Abstract]
Preferred stock, shares authorized (in shares)				1,000,000	1,000,000
Preferred stock, par value (in dollars per share) | $ / shares				$ 0.0001	$ 0.0001
Preferred stock, shares issued (in shares)				0	0
Preferred stock, shares outstanding (in shares)				0	0
Initial stockholders owned common stock after IPO percentage				20%
As-converted percentage for Class A ordinary shares after conversion of Class B shares				20%
Stock conversion basis of Class B to Class A ordinary shares at time of business combination				1
Class A Common Stock [Member]
Stockholders' Equity [Abstract]
Common stock, shares authorized (in shares)				100,000,000	100,000,000
Common stock, par value (in dollars per share) | $ / shares				$ 0.0001	$ 0.0001
Number of votes per share | Vote				1
Common stock, shares issued (in shares)				0	0
Common stock, shares outstanding (in shares)				0	0
Common stock, subject to possible redemption (in shares)				15,000,000	15,000,000
Class B Common Stock [Member]
Stockholders' Equity [Abstract]
Common stock, shares authorized (in shares)				50,000,000	50,000,000
Common stock, par value (in dollars per share) | $ / shares				$ 0.0001	$ 0.0001
Number of votes per share | Vote				1
Common stock, shares issued (in shares)				3,750,000	3,750,000
Common stock, shares outstanding (in shares)		4,312,500		3,750,000	3,750,000
Shares subject to forfeiture (in shares)				562,500	562,500
Number of shares forfeited (in shares)		4,312,500
Class B Common Stock [Member] | Maximum [Member]
Stockholders' Equity [Abstract]
Shares subject to forfeiture (in shares)		562,500
Institutional Anchor Investors [Member] | Class B Common Stock [Member]
Stockholders' Equity [Abstract]
Shares issued (in shares)	650,000
Share price (in dollars per share) | $ / shares	$ 0.003
Stock conversion basis of Class B to Class A ordinary shares at time of business combination	1
Directors [Member] | Class B Common Stock [Member]
Stockholders' Equity [Abstract]
Issuance of Class B ordinary shares to Sponsor (in shares)		75,000
Director 1 [Member] | Class B Common Stock [Member]
Stockholders' Equity [Abstract]
Issuance of Class B ordinary shares to Sponsor (in shares)		25,000
Director 2 [Member] | Class B Common Stock [Member]
Stockholders' Equity [Abstract]
Issuance of Class B ordinary shares to Sponsor (in shares)		25,000
Director 3 [Member] | Class B Common Stock [Member]
Stockholders' Equity [Abstract]
Issuance of Class B ordinary shares to Sponsor (in shares)		25,000
Sponsor [Member]
Stockholders' Equity [Abstract]
Proceeds from issuance of common stock | $				$ 25,000
Sponsor [Member] | Class A Common Stock [Member]
Stockholders' Equity [Abstract]
Share price (in dollars per share) | $ / shares				$ 12
Sponsor [Member] | Class B Common Stock [Member]
Stockholders' Equity [Abstract]
Common stock, par value (in dollars per share) | $ / shares			$ 0.0001
Issuance of Class B ordinary shares to Sponsor (in shares)			8,625,000
Proceeds from issuance of common stock | $			$ 25,000
Share price (in dollars per share) | $ / shares			$ 0.003
Number of shares forfeited (in shares)				562,500

CLASS A ORDINARY SHARES SUBJE_2

CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION (Details) - Class A Common Stock [Member]	9 Months Ended
	Sep. 30, 2022 Vote $ / shares shares	Dec. 31, 2021 $ / shares shares
Class A Ordinary Shares Subject to Possible Redemption [Abstract]
Common stock, shares authorized (in shares)	100,000,000
Common stock, par value (in dollars per share) | $ / shares	$ 0.0001	$ 0.0001
Number of votes per share | Vote	1
Common stock, subject to possible redemption (in shares)	15,000,000	15,000,000

FAIR VALUE MEASUREMENTS, Assets

FAIR VALUE MEASUREMENTS, Assets and Liabilities Measured at Fair Value (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Aug. 17, 2021
Warrants [Abstract]
Transfers into of Level 3	$ 0
Transfers out of Level 3	0
Class A Common Stock [Member]
Initial Measurement [Abstract]
Number of securities included in each unit (in shares)			1
Public Warrants [Member]
Initial Measurement [Abstract]
Number of securities included in each unit (in shares)			0.33
Level 1 [Member]
Liabilities [Abstract]
Warrant liabilities	0	$ 3,700,000
Recurring [Member] | Level 1 [Member]
Assets [Abstract]
Investments held in Trust Account	150,909,712	150,000,566
Recurring [Member] | Level 2 [Member] | Public Warrants [Member]
Liabilities [Abstract]
Warrant liabilities	500,000	0
Recurring [Member] | Level 3 [Member] | Private Placement Warrants [Member]
Liabilities [Abstract]
Warrant liabilities	$ 333,333	$ 2,500,000

FAIR VALUE MEASUREMENTS, Key In

FAIR VALUE MEASUREMENTS, Key Inputs (Details)	Sep. 30, 2022	Dec. 31, 2021
Valuation Technique and Input, Description [Abstract]
Expected term	5 years
Risk-free Interest Rate [Member]
Valuation Technique and Input, Description [Abstract]
Measurement input	0.0425	0.0135
Expected Term [Member]
Valuation Technique and Input, Description [Abstract]
Expected term	5 years	5 years
Expected Volatility [Member]
Valuation Technique and Input, Description [Abstract]
Measurement input	0.029	0.075
Exercise Price [Member]
Valuation Technique and Input, Description [Abstract]
Measurement input	11.5	11.5
Public Stock Price [Member]
Valuation Technique and Input, Description [Abstract]
Measurement input	9.7	9.82

FAIR VALUE MEASUREMENTS, Change

FAIR VALUE MEASUREMENTS, Change in Fair Value of Level 3 Warrant Liabilities (Details) - USD ($)		3 Months Ended				9 Months Ended
		Sep. 30, 2022		Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2022
Unobservable Input Reconciliation [Roll Forward]
Transfers into of Level 3						$ 0
Transfers out of Level 3						0
Private Placement Warrants [Member]
Unobservable Input Reconciliation [Roll Forward]
Fair value, beginning of period		$ 766,667		$ 1,533,333	$ 2,500,000	2,500,000
Change in valuation inputs or assumptions	[1]	(433,334)		(766,666)	(966,667)
Fair value, end of period		333,333	[2]	$ 766,667	$ 1,533,333	333,333	[2]
Public Warrants [Member]
Unobservable Input Reconciliation [Roll Forward]
Fair value, end of period		$ 500,000				$ 500,000
[1]Changes in valuation inputs or other assumptions are recognized in change in fair value of warrant liabilities in the condensed statement of operations.[2]Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period. There were no transfers in or out of Level 3 for the nine months ended September 30, 2022.